The US Federal Trade Commission held a two-day conference in Washington late last week to examine competition in the nation’s healthcare market, according to reports.
FTC Chairwoman Edith Ramirez launched the workshop early Thursday, telling attendees that “healthcare accounts for over 17 percent of GDP and study after study tells us that vigorous competition in healthcare markets reduces costs, improves quality and expands access to care for consumers.”
The regulator met to discuss regulatory oversight of the industry to promote innovation and increase price transparency in the industry.
The authority’s conference was open to the public; the FTC first requested public comment regarding competition in the healthcare market with a 50 questionnaire handout. Reports say the regulator is accepting public comment until the end of April.
Full Content: Health Data Management
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI